A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.

JCI Insight · 2022 · PMC8855826 · PMID 34908534

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although our sample size was insufficient to achieve statistical significance, a clear trend was observed with 100% 90-day survival in low NET producers (neutrophil NET release < cohort median), compared with only 60% 90-day survival in high NET producers (neutrophil NET release > median of cohort) ( Figure 6A ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.